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this question, Medtronic has recently begun the PIVOTAL trial,
which is designed to enroll 1700 patients with AAA of less than 5
cm, randomized to AneuRx treatment or observation.
Dr Zarins and colleagues have demonstrated that when com-
pared with small AAA, patients with large AAA have much poorer
long-term outcomes after EVAR. While this is not new informa-
tion, it bears repeating. It is well known that patients with larger
AAA have, on average, more unfavorable aortic neck anatomy.
However, when groups are controlled for variable anatomy and
other cohort differences, AAA size remains as independent risk
factor for poorer outcome. This was first demonstrated from the
EUROSTAR database and has been confirmed today.
How can this be explained? My hypothesis is a simple one. If
there is late endograft failure in a large AAA, the risk of subsequent
rupture is significant. However, if there is endograft failure in a
small AAA that already has a negligible risk of rupture, the inci-
dence of aneurysm-related problems is low.
Thus, knowing why endografts fail is crucial, especially if they
are being used to treat patients with a high risk of rupture. In The
Cleveland Clinic report of disparate outcome of small vs large
AAAs, there was a fourfold increase in type I endoleaks and a
threefold increase in migration in AAA greater than 5.5 cm (Ouriel
et al, J Vasc Surg 2003:37:1206). The EUROSTAR report dem-
onstrated similar findings (Peppelenbosch et al, J Vasc Surg 2004;
39:288-97). It is perplexing, therefore, that in the current study,
there were no differences in these outcome measures. This leads
me to my first question:
1. How do you explain the significant increase in AAA expansion
in the large AAA group compared to the smaller AAA group, if
there were no differences in endoleak or migration rates? Is it
simply a coincidence that a greater percentage of these patients
ultimately had rupture of their AAA?
2. At this meeting 3 years ago, you reported an 18.8% risk of
endograft migration at 3 years in this same cohort of AneuRx
patients, but in the current report, 3-year migration is reported
at about 5%. Please explain this discrepancy.
3. Migration is a time-dependent variable and must be reported
with Kaplan-Meier life-table analysis. To do otherwise is statis-
tically invalid and misleading. What are the 5-year Kaplan-
Meier estimates of freedom from migration in these patient
cohorts?
4. In patients with AAA 6 cm or greater, the curve of relative risk
of AAA rupture or aneurysm-related death remained fairly flat
in the first 4 years of follow-up but increased steeply between
the fourth and fifth year, going from approximately 4% to 8%.
Based on this disturbing geometric increase in late endograft
failure, should these patients have intensified surveillance?
Dr Christopher Zarins. In response to the question of
whether endografting can improve on the natural history of small
AAA, I would like to remind you that the UK and ADAM small
aneurysm trials reported a low risk of rupture in selected, good risk
patients who were closely monitored with ultrasound surveillance
every 3–6 months and promptly referred for surgery if the aneu-
rysm enlarged or became symptomatic. Despite this, 1% of the
small aneurysms ruptured each year—that is 5% in 5 years. Thus
ultrasound surveillance does not appear to have been a successful
strategy, particularly when rupture mortality was 90% and when
75% of the surveillance patients ultimately required surgery. In
contrast to surveillance of small aneurysms, endovascular repair
was very successful in our experience of small aneurysms 5 cm.
There were no ruptures over 5 years, only one aneurysm-related
death and only two surgical conversions. Clearly the size difference
in definition of small aneurysms is a critical factor in this difference
and this is one of the major points of this study. Aneurysms 5.5 cm
in diameter are average in size, not small.
I agree with Dr. Sternberg’s comments regarding large aneu-
rysms. Results are not as good as for small aneurysms and the risk
of late failure and rupture is higher. Since large aneurysms are more
likely to rupture if they are untreated, late device failures are a
greater concern in patients with large aneurysms. We did not note
a relationship between endoleak and enlargement in this study, but
this does not rule out this possibility. However, greater risk does
not mean that patients with large aneurysms should not be treated
with EVAR. Despite higher operative risk and less favorable anat-
omy, early results for large aneurysms are similar to smaller AAAs
with differences appearing only after 4 years. The cumulative
aneurysm related death rate for large aneurysms at 5 years is still
only 8%, which is considerably below the expected mortality from
rupture of non-treated large aneurysms.
With regard to migration, there is debate as to whether
Kaplan-Meier analysis is the preferred way to report migration
since migration is not a fixed endpoint, such as rupture or death,
and can start and stop. Kaplan-Meier analysis will give higher
estimates of migration and we have reported both Kaplan-Meier
estimates as well as migration prevalence rates at specific time
points in our previous migration analysis. In this study we focused
on primary outcome measures and reported migration, endoleak
and enlargement as prevalence rates at each annual follow up time,
since all are variable end-points.
Finally, Dr. Sternbergh asked about the increase in relative risk
of rupture and aneurysm related death after 4 years in large AAA
patients. Further follow up is needed to determine whether this risk
will continue to rise, but this finding highlights the importance of
life-long image based surveillance of patients with aneurysms 6
cm following endovascular repair. At the same time, the absence of
late rupture in patients with small aneurysms raises the question of
whether patients with aneurysms5 cm need less intensive follow
up and imaging following successful endovascular repair. Perhaps
this is where simple ultrasound surveillance will find a place. These
questions deserve further study. Our findings suggest that answers
to these questions may be easier to find by differentiation aneurysm
size groups into small (5 cm), medium (5-6 cm) and large (6
cm).
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This study demonstrates important differences in outcomes after
endovascular aneurysm repair (EVAR) that are associated with aneu-
rysm size. When reading this article, it is important to keep in mind a
critical fact: these patients were selected for repair at a given aneurysm
size. Decisions about aneurysm repair must be made within the
context of the natural history of the abdominal aortic aneurysm
(AAA), the risk of repair, and the patient’s life expectancy. The results
indicate that the surgeons in this clinical trial took these factors into
account when they selected patients for repair.
Patients with smaller aneurysms in this study were significantly
younger, had better operative risk, and had more favorable anat-
omy for EVAR. Their AAAs were likely repaired at a smaller size
because their life expectancy suggested potential benefit from
“early” repair1 or they had a higher than typical risk of rupture (eg,
female or family history of aneurysm)2 or both. It is logical to
assume that they had EVAR rather than open repair owing to
favorable anatomy for EVAR.
Older patients with more comorbidities might not have been
considered candidates for repair at a smaller aneurysm size because
they were not ideal candidates for either open repair or EVAR.
They underwent repair when the natural history of rupture became
worse than the expected results from repair. Less ideal anatomy for
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EVAR may have been accepted in these higher-risk patients be-
cause the alternative of open repair was worse.
The data suggest that the surgeons in this study achieved their
goal in most patients. Small AAAs selected for repair had a very low
rate of aneurysm-related death over 5 years—lower than one would
expect relative to the natural history of small aneurysms. Patients
with larger aneurysms selected for repair had worse outcomes than
patients with smaller aneurysms selected for repair, but still ap-
peared to receive benefit from repair. For patients with an AAA of
6 cm, the 92% freedom from aneurysm-related death over 5 years
in this study is not ideal, but still well below the expected natural
history of rupture.2 These data amplify the EUROSTAR data
indicating similar trends and suggesting a similar rationale for
patient selection.3
Thus, one should not infer from this study that all small
aneurysms should have EVAR, or that EVAR should be avoided in
large aneurysms. Yes, smaller aneurysms with good anatomy have
better outcomes than larger aneurysms, but these aneurysms should
have better outcomes to justify repair, because they also have a
lower risk of rupture during observation.
EVAR also remains appropriate in properly selected patients
with large aneurysms. The higher rates of rupture for large
aneurysms under observation and the greater incidence in large-
aneurysm patients in this study of such comorbidities as congestive
heart failure and chronic obstructive pulmonary disease, among
others, may still make EVAR the best option relative to open repair
or observation. Of course, not all patients with large aneurysms and
severe comorbidities should undergo EVAR, but this study indi-
cates that EVAR remains a reasonable option in properly selected
patients. Whether in clinical trials or in clinical practice, aneurysm
size should be taken into account, retaining the context of the risk
of rupture, the short-term and long-term risk of repair, and the
patient’s overall life expectancy.
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